Free Trial

Oscar Health, Inc. (NYSE:OSCR) Position Cut by Wells Fargo & Company MN

Oscar Health logo with Finance background

Wells Fargo & Company MN trimmed its position in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 14.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 127,012 shares of the company's stock after selling 21,651 shares during the period. Wells Fargo & Company MN owned about 0.05% of Oscar Health worth $1,707,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of the company. KBC Group NV raised its stake in Oscar Health by 56.1% during the fourth quarter. KBC Group NV now owns 7,107 shares of the company's stock worth $96,000 after purchasing an additional 2,555 shares during the period. ORG Wealth Partners LLC purchased a new position in shares of Oscar Health in the 4th quarter worth $100,000. Alberta Investment Management Corp purchased a new stake in Oscar Health during the fourth quarter valued at about $138,000. Virtu Financial LLC acquired a new stake in Oscar Health during the fourth quarter worth about $140,000. Finally, Potentia Wealth acquired a new position in shares of Oscar Health in the 4th quarter valued at about $141,000. 75.70% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, Wells Fargo & Company downgraded shares of Oscar Health from an "overweight" rating to an "equal weight" rating and cut their target price for the company from $20.00 to $16.00 in a research note on Thursday, March 13th. Two analysts have rated the stock with a sell rating, three have issued a hold rating, two have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $20.21.

Read Our Latest Report on OSCR

Oscar Health Stock Performance

Shares of NYSE:OSCR traded up $0.15 on Thursday, reaching $13.16. 938,206 shares of the company's stock were exchanged, compared to its average volume of 3,903,395. Oscar Health, Inc. has a fifty-two week low of $11.20 and a fifty-two week high of $23.79. The business's 50-day moving average is $13.40 and its two-hundred day moving average is $14.74. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The firm has a market capitalization of $3.30 billion, a price-to-earnings ratio of -658.82 and a beta of 1.75.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its earnings results on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. As a group, equities research analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current year.

Oscar Health Profile

(Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Further Reading

Institutional Ownership by Quarter for Oscar Health (NYSE:OSCR)

Should You Invest $1,000 in Oscar Health Right Now?

Before you consider Oscar Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.

While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines